Skip to main content

Licensed Cannabis and Hemp Producer One World Pharma Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services

Written by Customer Service on . Posted in Public Companies.

GARDEN CITY, N.Y., July 23, 2021 (GLOBE NEWSWIRE) — One World Pharma (OTC: OWPC) (“One World” or the “Company”), a fully licensed cannabis and hemp producer in Colombia, today announces that it has retained CORE IR, a leading investor relations, public relations and strategic advisory firm, to assist the Company with investor relations, public relations and shareholder communications services.

CORE IR will focus on expanding market awareness for One World, conveying the company’s business model and growth strategies to the institutional and retail investment communities. CORE IR, a boutique Investor and Public Relations and strategic advisory firm, specializes in leveraging the most effective investment, growth and exposure strategies for small to mid-sized publicly traded and privately-held companies through an integrated approach to relationship development and corporate communications.

“We believe CORE IR’s integrated approach to communications will help One World Pharma to expand our breadth of both institutional and retail investors while clearly communicating our story to the public at large,” said One World CEO and NBA Hall of Fame inductee Isiah Thomas. “We have a unique story that we feel will continue to be well received as we continue on our growth trajectory.”

“CORE IR is a great fit for One World, and we are very pleased to have the opportunity to work with management in executing our integrated approach to help the company expand their outreach and exposure strategies. We look forward to raising market awareness and engagement with the investment communities and to assisting the company in achieving its goals,” added Scott Gordon, president of CORE IR.

About CORE IR
Headquartered in Garden City, New York, CORE IR is comprised of senior market and practice leaders with expertise in Institutional and Retail investor relations and integrated corporate communications and capital markets advisory services. CORE IR provides proprietary integrated Investor and Public Relations Solutions that yield targeted exposure for small to mid-sized companies. For more information, please visit www.coreir.com.

About One World Pharma

One World Pharma Inc. is a fully licensed cannabis and hemp producer with offices and operations in Las Vegas and Bogota and Popayan, Colombia. One World Pharma planted its first crop of cannabis in 2018 at its cultivation site in Popayan, Colombia, began harvesting commercially in the first quarter of 2020.  The company supplies its global clients with the highest quality industrial and commercial applications for cannabis, hemp and hemp byproducts, including derivatives in crude oil, distillate, and isolate forms with industrial scale production to serve global cannabis and hemp demand. Its products are produced and tested to GAP, GMP and ISO standards. As its name suggests, One World is also focused on environmental, social and governance (ESG) standards, with particular emphasis on its impact on the environment as well as ensuring that its employees, particularly those within its Colombia operations, are valued and recognized for their contributions, while simultaneously maintaining stewardship over their indigenous land.

Contact:
CORE IR
Jules Abraham
917-885-7378
julesa@coreir.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.